Cite
Hypertrophic preconditioning attenuates post-myocardial infarction injury through deacetylation of isocitrate dehydrogenase 2
MLA
Junbo Ge, et al. “Hypertrophic Preconditioning Attenuates Post-Myocardial Infarction Injury through Deacetylation of Isocitrate Dehydrogenase 2.” Acta Pharmacologica Sinica, vol. 42, June 2021, pp. 2004–15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1bc5de427df4e14048e1e3af7115961d&authtype=sso&custid=ns315887.
APA
Junbo Ge, Leilei Ma, Fei-juan Kong, Junjie Guo, Shijun Wang, Aijun Sun, Yuanji Ma, Zheng Dong, & Yunzeng Zou. (2021). Hypertrophic preconditioning attenuates post-myocardial infarction injury through deacetylation of isocitrate dehydrogenase 2. Acta Pharmacologica Sinica, 42, 2004–2015.
Chicago
Junbo Ge, Leilei Ma, Fei-juan Kong, Junjie Guo, Shijun Wang, Aijun Sun, Yuanji Ma, Zheng Dong, and Yunzeng Zou. 2021. “Hypertrophic Preconditioning Attenuates Post-Myocardial Infarction Injury through Deacetylation of Isocitrate Dehydrogenase 2.” Acta Pharmacologica Sinica 42 (June): 2004–15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1bc5de427df4e14048e1e3af7115961d&authtype=sso&custid=ns315887.